Market Cap: $2.11B
II
Immunome, Inc.
IMNM
NASDAQUSD
Market Cap: $2.11B
Aro Biotherapeutics Welcomes New Leadership to Drive siRNA Innovations Aro Biotherapeutics, a clinical-stage biotechnology company specializing in targeted short-interfering RNA (siRNA) medicines, und…
Immunome Strengthens Talent Pool with New Inducement Awards Immunome, Inc., a biotechnology company based in Bothell, Washington, is making significant strides in its commitment to advancing targeted…
Immunome Expands Workforce to Accelerate Cancer Therapy Development Immunome, Inc., a biotechnology firm focused on innovative cancer treatments, announces the addition of four new employees as part o…
Immunome Secures Significant Funding to Propel Cancer Therapy Development Immunome, Inc., a biotechnology firm based in Bothell, Washington, has successfully completed an underwritten public offering,…
Immunome Advances Targeted Cancer Therapies Through Public Offering Immunome, Inc., a biotechnology company based in Bothell, Washington, is making significant strides in its mission to develop innova…
Immunome Expands Workforce with Strategic Inducement Awards to Support Cancer Therapy Development Immunome, Inc., a biotechnology firm based in Bothell, Washington, continues to bolster its commitment…
Immunome Expands Talent Pool to Propel Cancer Therapy Development Immunome, Inc., a biotechnology firm based in Bothell, Washington, focuses on developing innovative therapies targeting cancer. The co…
Immunome Bolsters Workforce with Inducement Awards Amid Cancer Therapy Advancements Immunome, Inc., a biotechnology firm based in Bothell, Washington, takes a significant step forward in its talent ac…
Immunome Expands Workforce with Inducement Awards to Fortify Cancer Research Efforts Immunome, Inc., a biotechnology firm specializing in targeted cancer therapies, announces the granting of inducemen…
Immunome Advances Innovative Cancer Therapies Ahead of Key Conference Immunome, Inc., a biotechnology firm based in Bothell, Washington, is at the forefront of developing targeted cancer therapies. Th…
Immunome Advances Oncology Pipeline with Promising Developments Immunome, Inc., a biotechnology firm based in Bothell, Washington, is making significant strides in the oncology sector, particularly wi…
Immunome Accelerates Pipeline Development Amidst Financial Results Immunome, Inc., a Bothell, Washington-based biotechnology company, highlights its commitment to advancing innovative oncology therapi…
Immunome Expands Workforce to Accelerate Cancer Therapy Development Immunome, Inc., a biotechnology company focused on pioneering targeted cancer treatments, announces a significant workforce expansio…